Mammograms Specialist Lawrence MA

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct. It is not cancer, but it may, in some cases, become invasive cancer and spread to other tissues. Because they can’t predict which lesions will become invasive cancer and which will remain contained in the breast duct, doctors usually treat DCIS like cancer.

Silwan Chedid, MD
1 General St
Lawrence, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Tx Med Sch At San Antonio, San Antonio Tx 78284
Graduation Year: 1999
Hospital
Hospital: Univ Of Tex Md Anderson Cancer, Houston, Tx

Data Provided by:
Pedro M Sanz Altamira, MD
(978) 946-8230
70 East St
Methuen, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ De Sevilla, Fac De Med, Sevilla, Spain
Graduation Year: 1988
Hospital
Hospital: Lawrence General Hospital, Lawrence, Ma; Holy Family Hosp And Med Ctr, Methuen, Ma
Group Practice: Commonwealth Hematology Oncology Pc

Data Provided by:
Mai Tai Nguyen
(978) 686-9152
411 Merrimack St
Methuen, MA
Specialty
Hematology / Oncology

Data Provided by:
Ralph P Orlando, MD
(978) 372-7751
288 Groveland St
Haverhill, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Murat A Anamur, MD
(978) 934-8425
2 Hospital Dr
Lowell, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Istanbul Univ, Istanbul Tip Fak, Istanbul, Turkey
Graduation Year: 1981

Data Provided by:
Paul Jeffrey Spieler, MD
(978) 685-7811
70 East St
Methuen, MA
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1971

Data Provided by:
Yamil H Kouri, MD
(978) 685-7811
70 East St
Methuen, MA
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Languages
French, Spanish
Education
Medical School: Univ Of Pr Sch Of Med, San Juan Pr 00936
Graduation Year: 1985
Hospital
Hospital: Lawrence General Hospital, Lawrence, Ma; Holy Family Hosp And Med Ctr, Methuen, Ma
Group Practice: Commonwealth Hematology-Onclgy

Data Provided by:
Paul J Spieler
(978) 521-8590
62 Brown St
Haverhill, MA
Specialty
Hematology / Oncology

Data Provided by:
Richard Vincent Miron, MD
(978) 256-7747
1230 Bridge St
Lowell, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1968

Data Provided by:
Ronald Jay Kossow, MD
(978) 934-8494
1 Hospital Dr
Lowell, MA
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: New York Med Coll, Valhalla Ny 10595
Graduation Year: 1995

Data Provided by:
Data Provided by:

Mandatory Mammograms

Provided by: 

By Vonalda M. Utterback, CN

“Time to make breast pancakes,” says one friend of mine, referring to her scheduled mammography screening. And although she may crack jokes about the experience, she’s never once questioned the need for her annual pilgrimage, nor has her physician discussed the risks versus the benefits it entails. After all, if you are a woman aged 40 or beyond, yearly mammograms are simply de rigueur.

When your doctor refers you for a screening, he or she is likely following the guidelines of the two leading national cancer research and information organizations primarily responsible for setting public health policy on cancer screening: The private American Cancer Society (ACS) and the government’s National Cancer Institute (NCI). Both, along with other well-funded, high-profile organizations, such as Susan G. Komen for the Cure, recommend regular mammogram screening of symptom-free women beginning at age 40.

All this official blessing shouldn’t make regular screening mammography sacrosanct, however. In fact, it’s way past time for women to start asking hard questions about the exam’s efficacy and its potential harm, say many women’s health experts, advocates, and researchers. “Screening mammography is clearly a double-edged sword,” explains Lisa Schwartz, MD, co-director of the Veteran’s Administration Outcomes Group in White River Junction, Vermont, and associate professor of medicine at Dartmouth Medical School.

False truths
According to the National Academy of Sciences 2005 publication, Saving Women’s Lives: Strategies for Improving Breast Cancer Detection and Diagnosis, the risk of a false-positive result in a mammogram is about 1 in 10. About three-quarters of the resulting biopsies turn out to be benign, it’s true, but to learn that a woman has to endure the fear that she has breast cancer and bear the cost, discomfort, and risk of additional medical procedures.

“Regular screening will save some lives, but it will cause even more women to be harmed through the unnecessary diagnosis and treatment of cancer that would never have affected their health, were it not for screening,” says Schwartz. She’s referring to false-positives associated with “ductal carcinoma in situ” (DCIS), a result that many experts consider one of the most harmful risks associated with screening mammography.

DCIS is a noninvasive condition in which abnormal cells are found in the lining of a breast duct. It is not cancer, but it may, in some cases, become invasive cancer and spread to other tissues. Because they can’t predict which lesions will become invasive cancer and which will remain contained in the breast duct, doctors usually treat DCIS like cancer. “Most women with DCIS will be advised to undergo invasive treatment of unknown benefit, such as lumpectomy combined with radiation,” reports Schwartz.
Harm from over-diagnosis of invasive cancer also may occur because many malignant cancers grow quite slowly, says Peter C. Gotzsche, MD, r...

Author: Vonalda M. Utterback, CN

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...